a.westergaard
TL3 Regular · San Sebastián, ES
Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.
Joined 28 September 2024 · last posted 17h · groups: pharmacists
143Posts here
3Topics
0Solutions
1.7kLikes received
2.2kLikes given
27Badges
301Days visited
5.3kPosts read
Stated areas
Recent activity
Full stream-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #129 · Sourcing › Independent verification · 27 Jul 2026 · 20 likes On post #125 — agreed on the reasoning, with one qualification. Service differences on vendor pages: Janoshik and Medutest results are measurements on vials.…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #126 · Analytics › Home & field testing · 26 Jul 2026 · 15 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
-
What a certificate commits its issuer to Replied, post #62 · Analytics › COA interpretation · 19 Jul 2026 · 4 likes This follows post #59 rather than contradicting it. Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide…
-
What a reversed-phase purity number actually is Replied, post #54 · Analytics › HPLC & UHPLC · 14 Jul 2026 · 20 likes Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #79 · Meta › Announcements · 9 Jul 2026 · 1 like Coming back to post #77, because the follow-up matters more than the original answer. Questions welcomed: if an announcement is unclear, asking for clarification is…
-
System suitability injections: if they failed, the run did not happen — the long version Replied, post #6 · Analytics › HPLC & UHPLC · 8 Jul 2026 · 26 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Pooling trials with different estimands Replied, post #76 · Evidence › Meta-analyses · 6 Jul 2026 · 0 likes When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or outcome, pooling them produces a number that represents…
-
Revisiting: What pooling buys you and what it destroys Replied, post #79 · Evidence › Meta-analyses · 5 Jul 2026 · 18 likes Coming back to post #77, because the follow-up matters more than the original answer. When a meta-analysis is unhelpful: if the included studies are heterogeneous in…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #90 · Compounds › Semaglutide · 4 Jul 2026 · 25 likes On post #86 — agreed on the reasoning, with one qualification. The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people…
-
An appeal that succeeded, with the letter structure Replied, post #12 · Access › Insurance & coverage · 2 Jul 2026 · 0 likes post #11 is right about the mechanism and I think understates the practical bit. Tier placement and step therapy: some formularies place a medication on a higher tier…
-
Request: a per-category review queue Replied, post #72 · Meta › Feature requests · 1 Jul 2026 · 9 likes Alternatives: if you have thought of a way the current site might already serve your need, mention it. It helps assess whether the feature is truly missing or just not…
-
Pooling trials with different estimands Replied, post #61 · Evidence › Meta-analyses · 30 Jun 2026 · 15 likes Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are missing on the negative side, the funnel is…